Renaissance Technologies's FBLG Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 231,600 shares of FibroBiologics, Inc. (FBLG) worth $52,087, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Renaissance Technologies has initiated a new position in FBLG, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 171,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's FibroBiologics (FBLG) Holding Value Over Time
Track share changes against reported price movement
Quarterly FibroBiologics (FBLG) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +171,800 | Add 287.29% | 231,600 | $0.22 |
| Q3 2025 | +59,800 | New Buy | 59,800 | $0.55 |
Renaissance Technologies's FibroBiologics Investment FAQs
Renaissance Technologies first purchased FibroBiologics, Inc. (FBLG) in Q3 2025, acquiring 59,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held FibroBiologics, Inc. (FBLG) for 2 quarters since Q3 2025.
Renaissance Technologies's largest addition to FibroBiologics, Inc. (FBLG) was in Q4 2025, adding 231,600 shares worth $52,087.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 231,600 shares of FibroBiologics, Inc. (FBLG), valued at approximately $52,087.
As of the Q4 2025 filing, FibroBiologics, Inc. (FBLG) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in FibroBiologics, Inc. (FBLG) was 231,600 shares, as reported at the end of Q4 2025.